Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.
In 2018, the global Narcolepsy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Narcolepsy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Narcolepsy Therapeutics development in United States, Europe and China.

The key players covered in this study
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Shire
Ligand Pharmaceuticals, Inc.

Market segment by Type, the product can be split into
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others

Market segment by Application, split into
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Narcolepsy Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Narcolepsy Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Narcolepsy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.